After completing a Bachelor of Science Honours degree at Queen’s University, Dr. Burnier pursued a PhD in molecular and cell biology at McGill University (Experimental Medicine). The focus of her PhD was the molecular mechanisms underlying invasion and metastasis. Dr. Burnier went on to become a post-doctoral researcher in clinical research at McGill, where she studied the role of inhibitors of growth in a metastasis model. She then pursued her second postdoctoral fellowship at the Centre for Genomic Regulation (Barcelona, Spain) with a focus on Systems Biology and Proteomics in cancer and later joined IMS as a consultant for the pharmaceutical industry (London, UK). Most recently, Dr. Burnier was a Research Associate in the Department of Medical Oncology, Drug Development Program, at Princess Margaret Hospital (Toronto) where she focused on correlative and translational science in oncology clinical trials. In her academic career, Dr. Burnier has supervised several students and presented her work at numerous international conferences. She has published 18 original articles as well as a book, several book chapters and reviews. She is also a regular reviewer for many prestigious journals and has worked as a freelance science editor, reviewing more than 100 manuscripts for scientists, physicians and industry.